Get App Open
In App
Open App
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 09, 12:38
990.85
9.9 (1.01%)
VOLUME 67,973
LIVE
NSE
Dec 09, 12:38
990.65
9.85 (1%)
VOLUME 2,431,518
News on Sun Pharmaceutical Industries
Select Year: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun Pharma's Halol facility listed under USFDA import alert

1.18 pm | 08 Dec 2022 |  Source: PTI

The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022....

Buy Sun Pharmaceuticals Industries; target of Rs 1300: Sharekhan

10.28 am | 08 Dec 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report d...

Sun Pharma gets USFDA nod for drug to treat neonatal seizures

2.08 pm | 18 Nov 2022 |  Source: PTI

SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection....

Sun Pharma inks licensing pact with SPARC to commercialise medication in US market

2.20 pm | 09 Nov 2022 |  Source: PTI

The Mumbai-based drug maker has inked a pact with Sun Pharma Advanced Research Company (SPARC) to commercialise benzyl alcohol and propylene glycol-fr...

India Inc throws up a mixed bag in Q2 amid global headwinds, local play stays strong

3.37 pm | 08 Nov 2022 |  Source: Moneycontrol.com

Excluding global cyclicals, profits of the Nifty50 companies would have grown 25 percent on-year, while, excluding BFSI companies, profits would have ...

Buy Sun Pharmaceutical Industries; target of Rs 1300: Sharekhan

10.45 pm | 03 Nov 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report da...

Buy Sun Pharmaceutical Industries; target of Rs 1300: Sharekhan

10.45 pm | 03 Nov 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report da...

Buy Sun Pharmaceutical Industries; target of Rs 1175: Prabhudas Lilladher

7.39 pm | 02 Nov 2022 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1175 in its research...

Sun Pharma Consolidated September 2022 Net Sales at Rs 10,952.28 crore, up 13.78% Y-o-Y

11.00 pm | 01 Nov 2022 |  Source: Moneycontrol.com

NULL...

Sun Pharma Standalone September 2022 Net Sales at Rs 5,285.29 crore, up 27.57% Y-o-Y

10.55 pm | 01 Nov 2022 |  Source: Moneycontrol.com

NULL...

Sun Pharma consolidated net profit rises more than 8%, beats estimate

1.46 pm | 01 Nov 2022 |  Source: Moneycontrol.com

The drugmaker reported 13.8 percent growth in consolidated revenue from operations...

Q2 Preview | Sun Pharma consolidated net may drop 4% on high R&D costs

1.32 pm | 31 Oct 2022 |  Source: Moneycontrol.com

Sun Pharmaceutical’s consolidated revenues, however, are expected to rise 13.2 percent on a year-on-year basis aided by growth in US specialty produ...

Sun Pharma: Slowdown in speciality clinical trials needs to be watched

11.56 am | 03 Aug 2022 |  Source: Moneycontrol.com

For FY23, we continue with the estimates that the top line of Sun Pharma would grow in a high single digit only...

Sun Pharma: Slowdown in speciality clinical trials needs to be watched

11.56 am | 03 Aug 2022 |  Source: Moneycontrol.com

Drug company posts healthy set of numbers with improvement in margins...

Sun Pharma: Slowdown in speciality clinical trials needs to be watched

11.56 am | 03 Aug 2022 |  Source: Moneycontrol.com

Drug company posts healthy set of numbers with improvement in margins...

Buy Sun Pharmaceuticals Industries; target of Rs 1130: Sharekhan

6.21 pm | 02 Aug 2022 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1130 in its research report d...

Buy Sun Pharmaceutical Industries; target of Rs 1070: Prabhudas Lilladher

5.57 pm | 02 Aug 2022 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1070 in its research...

Buy Sun Pharmaceutical Industries; target of Rs 1070: Prabhudas Lilladher

5.57 pm | 02 Aug 2022 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1070 in its research...

Buy Sun Pharma; target of Rs 1100: Motilal Oswal

5.24 pm | 01 Aug 2022 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1100 in its research report dated July 30, 2022....

Buy Sun Pharmaceutical Industries; target of Rs 1125: ICICI Direct

4.46 pm | 01 Aug 2022 |  Source: Moneycontrol.com

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1125 in its research report...

1 2
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.